255 studies found for:    Open Studies | "Urinary Bladder Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Urinary Bladder Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy
Conditions: Bladder Cancer;   Bladder Carcinoma;   Transition Cell Cancer;   Muscle Invasive Bladder Carcinoma
Interventions: Procedure: Transurethral Resection of the Bladder Tumor & Cystoscopy;   Drug: Cisplatin;   Drug: Gemcitabine;   Radiation: Intensity Modulated Radiation Therapy;   Behavioral: Quality of Life Questionnaires;   Genetic: Urine Collection for Molecular Analysis;   Genetic: Blood Collection for Molecular Analysis
2 Recruiting Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms
Condition: Urinary Bladder Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
3 Recruiting Adjuvant Radiation for High Risk Bladder Cancer
Conditions: Bladder Cancer;   Squamous Cell Carcinoma of the Bladder;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Radiation: 3D conformal radiation therapy;   Procedure: quality-of-life assessment;   Procedure: therapeutic conventional surgery
4 Recruiting Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer
Conditions: Recurrent Bladder Carcinoma;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Sirolimus;   Procedure: Therapeutic Conventional Surgery
5 Recruiting MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
Conditions: No Evidence of Disease;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IVA Bladder Cancer;   Stage IVB Bladder Cancer
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
6 Unknown  Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Procedure: robot-assisted laparoscopic surgery;   Procedure: therapeutic conventional surgery;   Procedure: therapeutic laparoscopic surgery
7 Not yet recruiting uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer
Condition: Urinary Bladder Neoplasms
Interventions: Drug: Injection of 68Ga-NOTA-AE105;   Drug: Injection of 18F-FDG;   Device: Positron Emission Tomography and CT;   Device: Positron Emission Tomography and MRI
8 Unknown  Quality of Life in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: quality-of-life assessment;   Procedure: questionnaire administration
9 Not yet recruiting TURBt With Adjuvant Cryoablation to Treat Bladder Cancer
Condition: Urinary Bladder Neoplasms
Intervention: Procedure: Cryoablation
10 Unknown  Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: selenium;   Drug: vitamin E;   Procedure: biopsy;   Procedure: chemoprevention;   Procedure: cryopreservation;   Procedure: cytology specimen collection procedure;   Procedure: diagnostic procedure;   Procedure: gene expression analysis;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: medical chart review;   Procedure: mutation analysis;   Procedure: polymerase chain reaction;   Procedure: quality-of-life assessment;   Procedure: questionnaire administration;   Procedure: study of socioeconomic and demographic variables
11 Recruiting 3 Tesla MRI in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: Specimen Ultra-High field MRI;   Drug: chemotherapy;   Procedure: Cystectomy and Lymphadenectomy
12 Unknown  Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: medical chart review;   Procedure: questionnaire administration;   Procedure: study of socioeconomic and demographic variables
13 Recruiting Laser En Bloc Resection Of Bladder Tumor (HoLERBT) VS. Conventional Transurethral Resection Of Bladder Tumors (cTURBT)
Condition: Bladder Cancer
Interventions: Device: HoLERBT;   Device: cTURBT
14 Unknown  Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: selenium;   Drug: vitamin E;   Procedure: chemoprevention
15 Unknown  A Study for Treatment of Superficial Bladder Cancer Using OGX-427
Condition: Bladder Cancer
Intervention: Drug: OGX-427
16 Recruiting Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery
Conditions: Bladder Carcinoma;   Recurrent Bladder Carcinoma
Interventions: Drug: Erlotinib Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Placebo;   Procedure: Therapeutic Conventional Surgery
17 Unknown  Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: sorafenib tosylate;   Other: imaging biomarker analysis;   Other: laboratory biomarker analysis;   Procedure: computed tomography;   Procedure: neoadjuvant therapy;   Radiation: fludeoxyglucose F 18
18 Recruiting MK-3475/BCG in High Risk Superficial Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: Intravenous MK-3475/ Intravesical BCG
19 Unknown  Tamoxifen in Treating Patients With Metastatic Bladder Cancer That Did Not Respond to Previous Chemotherapy
Condition: Bladder Cancer
Interventions: Drug: tamoxifen citrate;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
20 Recruiting PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors
Condition: Bladder Cancer
Interventions: Device: Monopolar electrocautery loop in Transurethral resection of bladder tumors;   Device: PK Button Vaporization Electrode in transurethral resection of bladder tumors

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years